Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.17% | 7.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.17% | 7.60% | |||
| Cost of Revenue | -0.05% | 7.55% | |||
| Gross Profit | 10.55% | 7.78% | |||
| SG&A Expenses | 9.97% | -9.38% | |||
| Depreciation & Amortization | -16.84% | 345.96% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.22% | 11.26% | |||
| Operating Income | 30.72% | -140.63% | |||
| Income Before Tax | 27.59% | -537.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.59% | -537.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.59% | -588.21% | |||
| EBIT | 30.72% | -140.63% | |||
| EBITDA | 5.21% | 240.35% | |||
| EPS Basic | 29.26% | -584.13% | |||
| Normalized Basic EPS | 29.04% | -15,250.00% | |||
| EPS Diluted | 26.23% | -584.13% | |||
| Normalized Diluted EPS | 29.04% | -15,250.00% | |||
| Average Basic Shares Outstanding | 2.39% | 1.04% | |||
| Average Diluted Shares Outstanding | 2.39% | -4.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||